Combination immunotherapy of B-cell non-Hodgkin's lymphoma with rituximab and interleukin-2: a preclinical and phase I study. [electronic resource]
Producer: 20050111Description: 6101-10 p. digitalISSN:- 1078-0432
- Adult
- Aged
- Aged, 80 and over
- Animals
- Antibodies, Monoclonal -- administration & dosage
- Antibodies, Monoclonal, Murine-Derived
- Antineoplastic Agents -- administration & dosage
- Combined Modality Therapy -- methods
- Female
- Humans
- Immunotherapy -- methods
- Interleukin-2 -- administration & dosage
- Killer Cells, Natural -- immunology
- Leukocytes -- immunology
- Leukocytes, Mononuclear -- metabolism
- Lymphoma, B-Cell -- immunology
- Lymphoma, Non-Hodgkin -- immunology
- Male
- Mice
- Mice, SCID
- Middle Aged
- Rituximab
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.